Drug intelligence / Profile preview

Tinfix

Development stage: Unknown
Lead developer: Novanta
Modality: Small Molecules
Administration: Oral

Overview

Tinfix is an oral third-generation cephalosporin antibiotic containing cefixime trihydrate, developed and marketed by Arges Life Science. It is a broad-spectrum bactericidal agent that works by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs). Tinfix is indicated for the treatment of various bacterial infections, including uncomplicated urinary tract infections, otitis media, pharyngitis, tonsillitis, acute bronchitis, acute exacerbations of chronic bronchitis, and uncomplicated gonorrhea. It is available in capsule and oral suspension (syrup) formulations and is primarily marketed in South Asian regions such as Bangladesh.

Brand names: TinfixTinfix-200Tinfix200Tinfix 200Tinfix-400Tinfix400Tinfix 400Tinfix-PFS
Other names: cefixime trihydrate

Targets

PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on Tinfix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tinfix.

Explore the full profile